158 related articles for article (PubMed ID: 25806888)
1. Richter syndrome: an aggressive transformation.
Streu E
Oncol Nurs Forum; 2015 Mar; 42(2):200-3. PubMed ID: 25806888
[TBL] [Abstract][Full Text] [Related]
2. Richter's transformation of chronic lymphocytic leukemia.
Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
[No Abstract] [Full Text] [Related]
3. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
[TBL] [Abstract][Full Text] [Related]
4. Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
Tadmor T; Bejar J; Attias D; Polliack A
Br J Haematol; 2011 Oct; 155(2):135. PubMed ID: 21973072
[No Abstract] [Full Text] [Related]
5. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
6. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
[TBL] [Abstract][Full Text] [Related]
7. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
8. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
9. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
Klintman J; Appleby N; Stamatopoulos B; Ridout K; Eyre TA; Robbe P; Pascua LL; Knight SJL; Dreau H; Cabes M; Popitsch N; Ehinger M; Martín-Subero JI; Campo E; Månsson R; Rossi D; Taylor JC; Vavoulis DV; Schuh A
Blood; 2021 May; 137(20):2800-2816. PubMed ID: 33206936
[TBL] [Abstract][Full Text] [Related]
10. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
11. Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.
Fornecker LM; Aurran-Schleinitz T; Michallet AS; Cazin B; Guieze R; Dilhuydy MS; Zini JM; Tomowiak C; Lepretre S; Cymbalista F; Brion A; Feugier P; Delmer A; Leblond V; Ysebaert L
Am J Hematol; 2015 Jun; 90(6):511-4. PubMed ID: 25752923
[TBL] [Abstract][Full Text] [Related]
12. Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
Langerbeins P; Busch R; Anheier N; Dürig J; Bergmann M; Goebeler ME; Hurtz HJ; Stauch MB; Stilgenbauer S; Döhner H; Fink AM; Cramer P; Fischer K; Wendtner CM; Hallek M; Eichhorst B
Am J Hematol; 2014 Dec; 89(12):E239-43. PubMed ID: 25196783
[TBL] [Abstract][Full Text] [Related]
13. Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.
Gajendra S; Jha B; Goel S; Sahni T; Dorwal P; Sachdev R
Turk J Haematol; 2015 Dec; 32(4):371-2. PubMed ID: 26376833
[No Abstract] [Full Text] [Related]
14. Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
Robak T; Dmoszynska A; Solal-Céligny P; Warzocha K; Loscertales J; Catalano J; Afanasiev BV; Larratt L; Geisler CH; Montillo M; Zyuzgin I; Ganly PS; Dartigeas C; Rosta A; Maurer J; Mendila M; Saville MW; Valente N; Wenger MK; Moiseev SI
J Clin Oncol; 2010 Apr; 28(10):1756-65. PubMed ID: 20194844
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's lymphoma variant of Richter's syndrome.
Vasilj A; Kojić-Katović S; Maricević I; Zokvić E; Kelcec IB; Tomas D; Curić-Jurić S
Coll Antropol; 2010 Mar; 34(1):295-9. PubMed ID: 20437646
[TBL] [Abstract][Full Text] [Related]
16. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Adiga GU; Abebe L; Wiernik PH
Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China.
Wu YX; Liu B; Chen L; Li JH; Chen SQ
Ann Hematol; 2013 Jun; 92(6):861-2. PubMed ID: 23238898
[No Abstract] [Full Text] [Related]
18. Epitrochlear lymphadenopathy.
Pannu AK; Prakash G; Jandial A; Kopp CR; Kumari S
Korean J Intern Med; 2019 Nov; 34(6):1396. PubMed ID: 30514055
[No Abstract] [Full Text] [Related]
19. Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia.
Robak E; Góra-Tybor J; Kordek R; Wawrzyniak E; Bartkowiak J; Bednarek A; Constantinou M; Kałuzewski B; Robak T
Br J Dermatol; 2005 Oct; 153(4):833-7. PubMed ID: 16181471
[TBL] [Abstract][Full Text] [Related]
20. Orbital richter syndrome.
Kiratli H; Tarlan B; Uzun S; Tanas Ö; Uner A
Orbit; 2013 Dec; 32(6):381-3. PubMed ID: 23895640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
